Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Interlaboratory Study on Zebrafish in Toxicology: Systematic Evaluation of the Application of Zebrafish in Toxicology's (SEAZIT's) Evaluation of Developmental Toxicity.
Hamm JT, Hsieh JH, Roberts GK, Collins B, Gorospe J, Sparrow B, Walker NJ, Truong L, Tanguay RL, Dyballa S, Miñana R, Schiavone V, Terriente J, Weiner A, Muriana A, Quevedo C, Ryan KR. Hamm JT, et al. Among authors: gorospe j. Toxics. 2024 Jan 22;12(1):93. doi: 10.3390/toxics12010093. Toxics. 2024. PMID: 38276729 Free PMC article.
Evaluation of 5-day In Vivo Rat Liver and Kidney With High-throughput Transcriptomics for Estimating Benchmark Doses of Apical Outcomes.
Gwinn WM, Auerbach SS, Parham F, Stout MD, Waidyanatha S, Mutlu E, Collins B, Paules RS, Merrick BA, Ferguson S, Ramaiahgari S, Bucher JR, Sparrow B, Toy H, Gorospe J, Machesky N, Shah RR, Balik-Meisner MR, Mav D, Phadke DP, Roberts G, DeVito MJ. Gwinn WM, et al. Among authors: gorospe j. Toxicol Sci. 2020 Aug 1;176(2):343-354. doi: 10.1093/toxsci/kfaa081. Toxicol Sci. 2020. PMID: 32492150 Free PMC article.
Preclinical toxicity evaluation of JD5037, a peripherally restricted CB1 receptor inverse agonist, in rats and dogs for treatment of nonalcoholic steatohepatitis.
Kale VP, Gibbs S, Taylor JA, Zmarowski A, Novak J, Patton K, Sparrow B, Gorospe J, Anand S, Cinar R, Kunos G, Chorvat RJ, Terse PS. Kale VP, et al. Among authors: gorospe j. Regul Toxicol Pharmacol. 2019 Dec;109:104483. doi: 10.1016/j.yrtph.2019.104483. Epub 2019 Sep 30. Regul Toxicol Pharmacol. 2019. PMID: 31580887 Free PMC article.
The 2023 Impact of Inflammatory Bowel Disease in Canada: Special Populations-IBD in Seniors.
Shaffer SR, Kuenzig ME, Windsor JW, Bitton A, Jones JL, Lee K, Murthy SK, Targownik LE, Peña-Sánchez JN, Rohatinsky N, Ghandeharian S, Tandon P, St-Pierre J, Natt N, Davis T, Weinstein J, Im JHB, Benchimol EI, Kaplan GG, Goddard Q, Gorospe J, Bergevin M, Silver K, Bowles D, Stewart M, Pearlstein M, Dawson EH, Bernstein CN. Shaffer SR, et al. Among authors: gorospe j. J Can Assoc Gastroenterol. 2023 Sep 5;6(Suppl 2):S45-S54. doi: 10.1093/jcag/gwad013. eCollection 2023 Sep. J Can Assoc Gastroenterol. 2023. PMID: 37674503 Free PMC article. Review.
The 2023 Impact of Inflammatory Bowel Disease in Canada: Cancer and IBD.
Murthy SK, Kuenzig ME, Windsor JW, Matthews P, Tandon P, Benchimol EI, Bernstein CN, Bitton A, Coward S, Jones JL, Kaplan GG, Lee K, Targownik LE, Peña-Sánchez JN, Rohatinsky N, Ghandeharian S, Meka S, Chis RS, Gupta S, Cheah E, Davis T, Weinstein J, Im JHB, Goddard Q, Gorospe J, Loschiavo J, McQuaid K, D'Addario J, Silver K, Oppenheim R, Singh H. Murthy SK, et al. Among authors: gorospe j. J Can Assoc Gastroenterol. 2023 Sep 5;6(Suppl 2):S83-S96. doi: 10.1093/jcag/gwad006. eCollection 2023 Sep. J Can Assoc Gastroenterol. 2023. PMID: 37674502 Free PMC article. Review.
The 2023 Impact of Inflammatory Bowel Disease in Canada: Treatment Landscape.
Murthy SK, Weizman AV, Kuenzig ME, Windsor JW, Kaplan GG, Benchimol EI, Bernstein CN, Bitton A, Coward S, Jones JL, Lee K, Peña-Sánchez JN, Rohatinsky N, Ghandeharian S, Sabrie N, Gupta S, Brar G, Khan R, Im JHB, Davis T, Weinstein J, St-Pierre J, Chis R, Meka S, Cheah E, Goddard Q, Gorospe J, Kerr J, Beaudion KD, Patel A, Russo S, Blyth J, Blyth S, Charron-Bishop D, Targownik LE. Murthy SK, et al. Among authors: gorospe j. J Can Assoc Gastroenterol. 2023 Sep 5;6(Suppl 2):S97-S110. doi: 10.1093/jcag/gwad015. eCollection 2023 Sep. J Can Assoc Gastroenterol. 2023. PMID: 37674501 Free PMC article. Review.
The 2023 Impact of Inflammatory Bowel Disease in Canada: Mental Health and Inflammatory Bowel Disease.
Graff LA, Geist R, Kuenzig ME, Benchimol EI, Kaplan GG, Windsor JW, Bitton A, Coward S, Jones JL, Lee K, Murthy SK, Peña-Sánchez JN, Targownik LE, Jannati N, Jones May T, Akhtar Sheekha T, Davis T, Weinstein J, Dahlwi G, Im JHB, Amankwah Osei J, Rohatinsky N, Ghandeharian S, Goddard Q, Gorospe J, Gertsman S, Louis M, Wagner R, Brass C, Sanderson R, Bernstein CN. Graff LA, et al. Among authors: gorospe j. J Can Assoc Gastroenterol. 2023 Sep 5;6(Suppl 2):S64-S75. doi: 10.1093/jcag/gwad012. eCollection 2023 Sep. J Can Assoc Gastroenterol. 2023. PMID: 37674499 Free PMC article. Review.
The 2023 Impact of Inflammatory Bowel Disease in Canada: The Influence of Sex and Gender on Canadians Living With Inflammatory Bowel Disease.
Targownik LE, Bollegala N, Huang VH, Windsor JW, Kuenzig ME, Benchimol EI, Kaplan GG, Murthy SK, Bitton A, Bernstein CN, Jones JL, Lee K, Peña-Sánchez JN, Rohatinsky N, Ghandeharian S, Davis T, Weinstein J, Im JHB, Jannati N, Khan R, Matthews P, Jones May T, Tabatabavakili S, Jogendran R, Hazan E, Browne M, Meka S, Vukovic S, Jogendran M, Hu M, Osei JA, Wang GY, Sheekha TA, Dahlwi G, Goddard Q, Gorospe J, Nisbett C, Gertsman S, Sousa J, Morganstein T, Stocks T, Weber A, Seow CH. Targownik LE, et al. Among authors: gorospe j. J Can Assoc Gastroenterol. 2023 Sep 5;6(Suppl 2):S55-S63. doi: 10.1093/jcag/gwad011. eCollection 2023 Sep. J Can Assoc Gastroenterol. 2023. PMID: 37674498 Free PMC article. Review.
The 2023 Impact of Inflammatory Bowel Disease in Canada: Special Populations-Children and Adolescents with IBD.
El-Matary W, Carroll MW, Deslandres C, Griffiths AM, Kuenzig ME, Mack DR, Wine E, Weinstein J, Geist R, Davis T, Chan J, Khan R, Matthews P, Kaplan GG, Windsor JW, Bernstein CN, Bitton A, Coward S, Jones JL, Lee K, Murthy SK, Targownik LE, Peña-Sánchez JN, Rohatinsky N, Ghandeharian S, Im JHB, Goddard Q, Gorospe J, Verdugo J, Morin SA, Morganstein T, Banning L, Benchimol EI. El-Matary W, et al. Among authors: gorospe j. J Can Assoc Gastroenterol. 2023 Sep 5;6(Suppl 2):S35-S44. doi: 10.1093/jcag/gwad016. eCollection 2023 Sep. J Can Assoc Gastroenterol. 2023. PMID: 37674497 Free PMC article. Review.
The 2023 Impact of Inflammatory Bowel Disease in Canada: Access to and Models of Care.
Mathias H, Rohatinsky N, Murthy SK, Novak K, Kuenzig ME, Nguyen GC, Fowler S, Benchimol EI, Coward S, Kaplan GG, Windsor JW, Bernstein CN, Targownik LE, Peña-Sánchez JN, Lee K, Ghandeharian S, Jannati N, Weinstein J, Khan R, Im JHB, Matthews P, Davis T, Goddard Q, Gorospe J, Latos K, Louis M, Balche N, Dobranowski P, Patel A, Porter LJ, Porter RM, Bitton A, Jones JL. Mathias H, et al. Among authors: gorospe j. J Can Assoc Gastroenterol. 2023 Sep 5;6(Suppl 2):S111-S121. doi: 10.1093/jcag/gwad007. eCollection 2023 Sep. J Can Assoc Gastroenterol. 2023. PMID: 37674496 Free PMC article. Review.
50 results